RVVRevive Therapeutics Ltd.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · revivethera.com

0.0250CADMkt Cap: 7.93M $P/E: —25d ago

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap7.93M $

Enterprise Value7.97M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-8.02M $

Revenue/Share—

Last Price0.0250 CAD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA7615161030

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-8.40

EV/Revenue—

P/S—

P/B-2.78

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.02500% of range0.0300

52W High0.0300 CAD

52W Low0.0250 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE318.64%

ROA-5370.77%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-559.06K $

CapEx (TTM)—

FCF Margin—

FCF Yield2.20%

Net Debt42.32K $

Net Debt/EBITDA-0.04

Balance Sheet

Debt/Equity-0.02

Current Ratio0.04

Quick Ratio0.02

Book Value/Sh-0.0090 CAD

Cash/Share0.0000 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.435.68M

Float429.35M

Insiders1.51%

Institutions0.00%

Short Interest

Short Ratio0.1d

Short % Out.0.00%

Shares Short33.31K

Short (prev mo.)9.63K

Technical

SMA 500.0287 (-12.9%)

SMA 2000.0247 (+1.3%)

Beta-1.85

S&P 52W Chg19.18%

Avg Vol (30d)146.34K

Avg Vol (10d)366.60K

Technical Indicators

RSI (14)44.1

MACD-0.0014

MACD Signal-0.0011

MACD Hist.-0.0003

BB Upper0.0340 CAD

BB Middle0.0280 CAD

BB Lower0.0220 CAD

BB Width42.73%

ATR (14)0.0031 CAD

Vol Ratio (20d)0.55x